Global ePrescribing Market by Component (Services, Solution), Deployment (On-Cloud, On-Premises), End-User - Forecast 2024-2030- Product Image

Sale

Global ePrescribing Market by Component (Services, Solution), Deployment (On-Cloud, On-Premises), End-User - Forecast 2024-2030

Report
193 Pages
March 2024
Region: Global
360iResearch™
ID: 4807798

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The ePrescribing Market size was estimated at USD 2.50 billion in 2023, USD 3.08 billion in 2024, and is expected to grow at a CAGR of 22.92% to reach USD 10.64 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the ePrescribing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the ePrescribing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the ePrescribing Market, highlighting leading vendors and their innovative profiles. These include ADP, Inc., Allscripts Healthcare, LLC, Arrive Health, Bizmatics Inc., CareCloud, Inc., Change Healthcare Holdings, Inc, Computer Programs and Systems, Inc., DAW Systems Inc, DrFirst.com, Inc., EPIC Systems Corporation, Greenway Health, LLC, Henry Schein, Inc., NextGen Healthcare, Inc., and Relayhealth Corporation.

Market Segmentation & Coverage

This research report categorizes the ePrescribing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Services
  - Maintenance & Support Services
  - Network & Implementation Services
  - Training & Education Services
- Solution
  - Integrated Solutions
  - Standalone Solutions
Deployment
- On-Cloud
- On-Premises
End-User
- Hospitals
- Long Term Care Providers
  - Assisted Living Facilities
  - Home Healthcare Facilities
  - Hospice
  - Nursing Facilities
- Pharmacies
- Physicians

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the ePrescribing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the ePrescribing Market?
What are the technology trends and regulatory frameworks in the ePrescribing Market?
What is the market share of the leading vendors in the ePrescribing Market?
Which modes and strategic moves are suitable for entering the ePrescribing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. ePrescribing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improving patient safety and reduce prescription errors
5.1.1.2. Increasing patient convenience and medication compliance
5.1.1.3. Drug abuse prevention and improved drug surveillance
5.1.2. Restraints
5.1.2.1. Implementation cost and ROI
5.1.2.2. Technical complexity and data availability
5.1.3. Opportunities
5.1.3.1. Integrated e-prescription software
5.1.3.2. Enforcement by HIPAA compliance
5.1.4. Challenges
5.1.4.1. Reluctance towards the adoption of technology
5.1.4.2. Patient information security issues
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. ePrescribing Market, by Component

6.1. Introduction
6.2. Services
6.3.1. Maintenance & Support Services
6.3.2. Network & Implementation Services
6.3.3. Training & Education Services
6.3. Solution
6.4.1. Integrated Solutions
6.4.2. Standalone Solutions

7. ePrescribing Market, by Deployment

7.1. Introduction
7.2. On-Cloud
7.3. On-Premises

8. ePrescribing Market, by End-User

8.1. Introduction
8.2. Hospitals
8.3. Long Term Care Providers
8.4.1. Assisted Living Facilities
8.4.2. Home Healthcare Facilities
8.4.3. Hospice
8.4.4. Nursing Facilities
8.4. Pharmacies
8.5. Physicians

9. Americas ePrescribing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific ePrescribing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa ePrescribing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. ADP, Inc.
13.1.2. Allscripts Healthcare, LLC
13.1.3. Arrive Health
13.1.4. Bizmatics Inc.
13.1.5. CareCloud, Inc.
13.1.6. Change Healthcare Holdings, Inc
13.1.7. Computer Programs and Systems, Inc.
13.1.8. DAW Systems Inc
13.1.9. DrFirst.com, Inc.
13.1.10. EPIC Systems Corporation
13.1.11. Greenway Health, LLC
13.1.12. Henry Schein, Inc.
13.1.13. NextGen Healthcare, Inc.
13.1.14. Relayhealth Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. EPRESCRIBING MARKET RESEARCH PROCESS
FIGURE 2. EPRESCRIBING MARKET SIZE, 2023 VS 2030
FIGURE 3. EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. EPRESCRIBING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. EPRESCRIBING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. EPRESCRIBING MARKET DYNAMICS
FIGURE 7. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 8. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
FIGURE 10. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. EPRESCRIBING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. EPRESCRIBING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. EPRESCRIBING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. EPRESCRIBING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EPRESCRIBING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 6. EPRESCRIBING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 8. EPRESCRIBING MARKET SIZE, BY MAINTENANCE & SUPPORT SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. EPRESCRIBING MARKET SIZE, BY NETWORK & IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. EPRESCRIBING MARKET SIZE, BY TRAINING & EDUCATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. EPRESCRIBING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 13. EPRESCRIBING MARKET SIZE, BY INTEGRATED SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. EPRESCRIBING MARKET SIZE, BY STANDALONE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 16. EPRESCRIBING MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. EPRESCRIBING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. EPRESCRIBING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 22. EPRESCRIBING MARKET SIZE, BY ASSISTED LIVING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. EPRESCRIBING MARKET SIZE, BY HOME HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. EPRESCRIBING MARKET SIZE, BY HOSPICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. EPRESCRIBING MARKET SIZE, BY NURSING FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. EPRESCRIBING MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. EPRESCRIBING MARKET SIZE, BY PHYSICIANS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 47. CANADA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. CANADA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 49. CANADA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 50. CANADA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 51. CANADA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. CANADA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 55. MEXICO EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 57. MEXICO EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MEXICO EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES EPRESCRIBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 79. CHINA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. CHINA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 81. CHINA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 82. CHINA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 83. CHINA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. CHINA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 85. INDIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 86. INDIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 87. INDIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 88. INDIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 89. INDIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. INDIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 97. JAPAN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 98. JAPAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. JAPAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 100. JAPAN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 101. JAPAN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. JAPAN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 133. THAILAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. THAILAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 136. THAILAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 137. THAILAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. THAILAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EPRESCRIBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 153. DENMARK EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 154. DENMARK EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 155. DENMARK EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 156. DENMARK EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. DENMARK EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 158. EGYPT EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. EGYPT EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. EGYPT EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 161. EGYPT EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 162. EGYPT EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. EGYPT EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 164. FINLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 165. FINLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 166. FINLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 167. FINLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 168. FINLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. FINLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 170. FRANCE EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 171. FRANCE EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 172. FRANCE EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 173. FRANCE EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 174. FRANCE EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 176. GERMANY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 177. GERMANY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 178. GERMANY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 179. GERMANY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 180. GERMANY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. GERMANY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 188. ITALY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 189. ITALY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. ITALY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 191. ITALY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 192. ITALY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. ITALY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 206. NORWAY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 207. NORWAY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 208. NORWAY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 209. NORWAY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 210. NORWAY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. NORWAY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 212. POLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 213. POLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 214. POLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 215. POLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 216. POLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. POLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 218. QATAR EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 219. QATAR EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 220. QATAR EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 221. QATAR EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 222. QATAR EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. QATAR EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 242. SPAIN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 243. SPAIN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 244. SPAIN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 245. SPAIN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 246. SPAIN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. SPAIN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 260. TURKEY EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 261. TURKEY EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 262. TURKEY EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 263. TURKEY EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 264. TURKEY EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. TURKEY EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY SOLUTION, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM EPRESCRIBING MARKET SIZE, BY LONG TERM CARE PROVIDERS, 2018-2030 (USD MILLION)
TABLE 278. EPRESCRIBING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 279. EPRESCRIBING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. EPRESCRIBING MARKET LICENSE & PRICING

Companies Mentioned

ADP, Inc.
Allscripts Healthcare, LLC
Arrive Health
Bizmatics Inc.
CareCloud, Inc.
Change Healthcare Holdings, Inc
Computer Programs and Systems, Inc.
DAW Systems Inc
DrFirst.com, Inc.
EPIC Systems Corporation
Greenway Health, LLC
Henry Schein, Inc.
NextGen Healthcare, Inc.
Relayhealth Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	193
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.08 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.64 Billion
Compound Annual Growth Rate	22.9%
Regions Covered	Global
No. of Companies Mentioned	14

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Digital Health Market by Revenue Model (Subscription, Pay per service, Free apps), Technology (Wearables, mHealth, Telehealthcare, RPM, LTC monitoring, Population Health management, DTx), EHR, Healthcare Analytics, ePrescribing & Region - Global Forecast to 2028

Global E-Healthcare Market by Type (Clinical Decision Support Systems, e-Prescribing, Electronic Health Records), Type of Service (Adherence Monitoring, Diagnosis Services, Monitoring Services), End-User - Forecast 2024-2030

E-Prescribing Global Market Report 2024

Global E-prescribing Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Global E-Prescribing Market Report and Forecast 2023-2031

About the E Prescription Market